December 18, 2019   LIGHT trial results: Repeat-SLT lowers IOP and keeps it there Prof Gus Gazzard shares how repeat-selective laser trabeculoplasty (SLT)—a protocol explored in a subset of patients in the SLT Laser in Glaucoma and Ocular Hypertension (LIGHT Trial)—successfully lowered the IOP in eyes in which the IOP increased after 1.5 years after the initial SLT application Read more ADVERTISEMENT   The Magnificent 7: How many glaucoma medications are too many? Finding the sweet spot surrounding the number of anti-glaucoma medications translates to a balancing act with focus on individual patient needs. Read more ADVERTISEMENT   Ultra-widefield OCT ‘may be the only imaging’ needed to manage PDR The use of ultra-widefield (UWF) imaging has shown the distribution of neovascularization and other diabetic retinopathy (DR) lesions in the posterior and peripheral retina Read more ADVERTISEMENT RELATED ARTICLES   Guidelines for treating the diabetic eye patient AI model predicts future DR progression in individual patients Database IDs risk factors for iris damage, dropped nucleus AMD risk phenotypes targeted in direct-to-consumer genetic database